Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice about government funding and a revision update to v3.4.1 were added, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check11 days agoChange DetectedThe Record History page introduces a 'Show glossary' option, color-coded indicators for changes, and updates the revision label to v3.4.0 (from v3.3.4).SummaryDifference1%

- Check18 days agoNo Change Detected
- Check46 days agoChange DetectedThe history page now includes Revision: v3.3.3, and the footer no longer lists HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.2%

- Check68 days agoChange DetectedA new revision entry v3.3.2 is added to the Record History and the previous entry v3.3.1 is removed.SummaryDifference0.1%

- Check75 days agoChange DetectedThe Record History now includes a new revision entry v3.3.1 and removes the older revision v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedThe government operating status notice at the top of the page was removed, and the rest of the study history content remains unchanged.SummaryDifference0.7%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.